Cancer

Health Angus Chen

STAT Plus: FDA alters warning label for Carvykti CAR-T, although link to secondary cancers is unclear

Morning Rounds Elizabeth Cooney

Morning Rounds: Our newsroom’s favorite stories of 2023

The Readout Damian Garde

STAT Plus: BioMarin appeases an activist

Health Shravya Pant — Medill News Service

Pregnant cancer patients often have to terminate. Abortion pill restrictions could make that choice even harder

The Readout Meghana Keshavan

STAT Plus: The biotech updates you need to read today

Biotech Andrew Joseph

STAT Plus: In the U.S., scientists see barriers to the development of CAR-T cell therapies. In Spain, a hospital brews its own

Health Adam Feuerstein

STAT Virtual Event | Cancer’s Breakthrough Engine

Pharmalot Ed Silverman

STAT Plus: Pharmalittle: Illumina will divest Grail after court finds deal was anti-competitive; FDA found problems at Moderna facility

Matt's Take Matthew Herper

STAT Plus: Illumina says it will divest Grail, starting a closing chapter for a disastrous deal

Morning Rounds Elizabeth Cooney

Morning Rounds: Teen pregnancies down, but remain higher in the U.S. 

Biotech Andrew Joseph

STAT Plus: Jay Bradner, former Novartis research leader, to head up Amgen’s scientific efforts

Morning Rounds Elizabeth Cooney

Morning Rounds: For kids with high BMI, task force not ready to recommend weight loss drugs

Health Elizabeth Cooney

Doctors call out ableism in cancer care: ‘The biggest accommodation is attitude’

Biotech Angus Chen

STAT Plus: A targeted therapy shows it can offer a ‘last, great chance’ for some acute leukemia patients

Pharma Jonathan Wosen

STAT Plus: Late-stage trial supports broader use of Darzalex, blockbuster J&J multiple myeloma drug

Biotech Allison DeAngelis

STAT Plus: With big ambition — and a family name to match — Reed Jobs charts his own course in biotech

First Opinion Shirley Leung

STAT Plus: Dana-Farber CEO Laurie Glimcher has always been a trailblazer and a risk taker

The Readout Theresa Gaffney

Morning Rounds: Preterm birth rates vary across the U.S., with the highest in the Southeast

The Readout Meghana Keshavan

STAT Plus: The biotech news you missed from the weekend

In the Lab Angus Chen

STAT Plus: CAR-T, recently used in a lupus patient, helps other autoimmune patients, too, in small study

Biotech Angus Chen

STAT Plus: Was CAR-T therapy a bystander or driver of lymphoma? Researchers examine first published case

Letters to the editor Torie Bosch

STAT readers on diagnostic tests, marijuana regulation, and pediatric oncology

Morning Rounds Elizabeth Cooney

STAT Plus: Morning Rounds: 3D-printed organs, antimicrobial resistance in Ukraine, and other major health stories of the day

Health Associated Press

White House delays menthol cigarette ban, alarming anti-smoking advocates

Health Elizabeth Cooney

STAT Plus: Using Pap smears for earlier ovarian cancer detection shows promise in small new study

The Readout Damian Garde

STAT Plus: Carmot’s chance of beating the odds in the biotech market just ended

Biotech Jason Mast

STAT Plus: New CAR-T company, Brainchild Bio, will focus first on brain tumors in children

Politics John Wilkerson

STAT Plus: Cancer drug shortages won’t get better under Biden’s latest plan

First Opinion E. Anders Kolb

A well-meaning FDA policy is a threat to pediatric cancer treatment